Bacterial cell wall components as immunomodulators -: I.: Lipopeptides as adjuvants for parenteral and oral immunization

被引:26
作者
Bessler, WG
Heinevetter, L
Wiesmüller, KH
Jung, G
Baier, W
Huber, M
Lorenz, AR
Esche, UVD
Mittenbühler, K
Hoffmann, P
机构
[1] Univ Freiburg, Inst Immunbiol, D-79104 Freiburg, Germany
[2] Deutsch Inst Ernahrungsforsch, D-14558 Potsdam, Germany
[3] NMI Reutlingen, D-72762 Reutlingen, Germany
[4] Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany
[5] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany
来源
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1997年 / 19卷 / 9-10期
关键词
adjuvants; lipopeptide; immunization; vaccines;
D O I
10.1016/S0192-0561(97)00054-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the immunostimulatory properties of synthetically prepared lipopeptides derived from the cell wall of Gram negative bacteria. These compounds constitute potent macrophage activators and polyclonal B-lymphocyte stimulators. They are also immunoadjuvants in parenteral or oral immunization. By coupling the lipopeptides to haptens or low molecular weight antigens which are not immunogenic per se, highly immunogenic conjugates can be prepared. Lipopeptide antigen conjugates as synthetic vaccines give protection by enhancing the antibody-mediated immune response, and they stimulate the cellular immune response in vivo by priming of cytotoxic T-cells. (C) 1998 Published by Elsevier Science Ltd on behalf of the International Society for Immunopharmacology.
引用
收藏
页码:547 / 550
页数:4
相关论文
共 15 条
[1]  
Bessler W G, 1997, Behring Inst Mitt, P390
[2]  
BESSLER WG, 1990, IMMUNOTHERAPEUTIC PR, P37
[3]  
BOLTZ T, 1988, LYMPHOCYTE ACTIVATIO, P379
[4]   INVIVO PRIMING OF VIRUS-SPECIFIC CYTO-TOXIC LYMPHOCYTES-T WITH SYNTHETIC LIPOPEPTIDE VACCINE [J].
DERES, K ;
SCHILD, H ;
WIESMULLER, KH ;
JUNG, G ;
RAMMENSEE, HG .
NATURE, 1989, 342 (6249) :561-564
[5]   Induction of an epitope-specific humoral immune response by lipopeptide-hapten conjugates: Enhancement of the anti-melittin response by a synthetic T helper (T-h)-cell epitope [J].
Hoffmann, P ;
Loleit, M ;
Mittenbuhler, K ;
Beck, W ;
Wiesmuller, KH ;
Jung, G ;
Bessler, WG .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1997, 17 (04) :225-234
[6]  
Hoffmann P, 1990, Hum Antibodies Hybridomas, V1, P137
[7]   CONJUGATES OF SYNTHETIC LYMPHOCYTE-ACTIVATING LIPOPEPTIDES WITH SEGMENTS FROM HIV PROTEINS INDUCE PROTEIN-SPECIFIC ANTIBODY-FORMATION [J].
LOLEIT, M ;
TROGER, W ;
WIESMULLER, KH ;
JUNG, G ;
STRECKER, M ;
BESSLER, WG .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1990, 371 (10) :967-975
[8]   Synthetic peptides coupled to the lipotripeptide P3CSS induce in vivo B and T-helper cell responses to HIV-1 reverse transcriptase [J].
Loleit, M ;
Ihlenfeldt, HG ;
Brunjes, J ;
Jung, G ;
Muller, B ;
Hoffmann, P ;
Bessler, WG ;
Pierres, M ;
Haas, G .
IMMUNOBIOLOGY, 1996, 195 (01) :61-76
[9]  
MULLER CP, 1989, CLIN EXP IMMUNOL, V78, P499
[10]   LIPOPEPTIDE DERIVATIVES OF BACTERIAL LIPOPROTEIN CONSTITUTE POTENT IMMUNE ADJUVANTS COMBINED WITH OR COVALENTLY COUPLED TO ANTIGEN OR HAPTEN [J].
REITERMANN, A ;
METZGER, J ;
WIESMULLER, KH ;
JUNG, G ;
BESSLER, WG .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1989, 370 (04) :343-352